Flagship Private Wealth, LLC Moderna, Inc. Transaction History

Flagship Private Wealth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 20, 2021	SELL	$221.9 - $484.47 $58,581 - $127,900	-264 Closed	0 $0
Q2 2021 Jul 09, 2021	SELL	$129.91 - $234.98 $7.58 Million - $13.7 Million	-58,317 Reduced 99.55%	264 $58.6 Million
Q2 2021 Jul 09, 2021	BUY	$129.91 - $234.98 $7.59 Million - $13.7 Million	58,448 Added 43945.86%	58,581 $13.8 Million
Q1 2021 Apr 09, 2021	SELL	$109.18 - $185.98 $79,483 - $135,393	-728 Reduced 84.55%	133 $17.3 Million
Q4 2020 Feb 02, 2021	BUY	$65.74 - $169.86 $56,602 - $146,249	861 New	861 $89,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Flagship Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Private Wealth, LLC with notifications on news.